Copyright (c) 2013 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Colourimetric Estimation of Escitalopram Oxalate in Formulation by Ion Association Complex with Methyl Orange
Corresponding Author(s) : Hyun Tae Jang
Asian Journal of Chemistry,
Vol. 25 No. 6 (2013): Vol 25 Issue 6
Abstract
A new and fully validated ion pair spectrophotometric method has been developed for estimation for escitalopram oxalate in bulk and tablet formulation using acidic methyl orange dye as an ion associating agent in the absence of buffer. The developed method is sensitive and specific for the intended purpose of estimation. Ion association complex of escitalopram oxalate and methyl orange obeys Beer's law in the range of 4-24 μg mL-1 of escitalopram oxalate with a correlation coefficient of 0.9987. Accuracy, precision, stability, LOD, LOQ, interference, robustness and ruggedness were studied for validation of the method. The results recovery with low % RSD of 0.88-1.02; precision is also good in agreement with validation limits. The method developed was successfully applied for the estimation of the escitalopram oxalate in its formulation.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Escitalopram oxalate. http://www.rxlist.com/cgi/generic/ lexapro.htm (Date accessed 03/01/2012).
- W.J. Burke and C.J. Kratochvil, Prim. Care Comp. J. Clin. Psychiatry, 4, 20 (2002).
- W.J. Burke, I. Gergel and A. Bose, J. Clin. Psychiatry, 63, 331 (2002).
- V.Y. Yevtushenko, A.I. Belous, Y.G. Yevtushenko, S.E. Gusinin, O.J. Buzik and T.V. Agibalova, Clin. Ther., 29, 2319 (2007).
- S. Schreiber and C.G. Pick, Eur. Neuropsychopharmacol., 16, 464 (2006).
- M.M. Gutierrez, J. Rosenberg and W. Abramowitz, Clin. Ther., 25, 1200 (2003).
- C. Sánchez, P.B. Bergqvist, L.T. Brennum, S. Gupta, S. Hogg, A. Larsen and O. Wiborg, Psychopharmacology, 167, 353 (2003).
- S. Budavari, The Merck Index, an Encyclopedia of Chemicals, Drugs and Biologicals. Edn. 14th , Merck and Co. Inc., Whitehouse Station, NJ (2001).
- S.S. Singh, H. Shah, S. Gupta, M. Jain, K. Sharma, P. Thakkar and R. Shah, J. Chromatogr. B., 811, 209 (2004).
- B. Raman, B.A. Sharma, P.D. Ghugare, S. Nandavadekar, D. Singh, P.K. Karmuse and A. Kumar, J. Pharm. Biomed. Anal., 53, 895 (2010).
- N. Johannesson and J. Bergquist, J. Pharm. Biomed. Sci., 43, 1045 (2007).
- C. Greiner, C. Hiemke, W. Bader and E. Haen, J. Chromatogr. B, 848, 391 (2007).
- M. Kosel, C.B. Eap, M. Amey and P. Baumann, J. Chromatogr. B., 719, 234 (1998).
- S. Andersen, T.G. Halvorsen, S. Pedersen-Bjergaard, K.E. Rasmussen, L. Tanum and H. Refsum, J. Pharm. Biomed. Anal., 33, 263 (2003).
- T. Samanta, S. Dey, H.B. Samal, D.B. Kumar, D.L. Mohanty and K. Bhar, Int. J. Chem. Res., 2, 11 (2011).
- A. Suneetha and B.S. Sundar, Int. J. Pharm. Biol. Sci., 2, 140 (2011).
- N. Dhavale, S. Gandhi, S. Sabnis and K. Bothara, Chromatographia, 67, 487 (2008).
- Y. Shete, N. Pimpodkar, N.S. Mahajan, Y.V. Pore, R.L. Jadhav and B.S. Kuchekar, Int. J. Chem. Sci., 7, 235 (2009).
- S. Sharma, H. Rajpurohit, C. Sonwal, A. Bhandari, V.R. Choudhary and T. Jainm J. Young Pharm., 2, 420 (2010).
- S.A. Al-Tamimi, F.A. Aly and O.M. Al-Otaibi, Asian J. Chem., 24, 5515 (2012).
- R.B. Kakde and D.D. Satone, Indian J. Pharm. Sci., 71, 702 (2009).
- B.G. Chaudhari and H.R. Parmar, Int. J. Pharm. Qual. Assur., 2, 9 (2010).
- T. Vetrichelvan, K. Arul, M. Sumithra and B. Umadevi, Indian J. Pharm. Sci., 72, 269 (2010).
- P. Job, in ed.: B. Oliner, Advanced Physico Chemical Experiments, Edinburgh, UK, p. 54 (1964).
- The United States Pharmacopeia, The National Formulary 19, US Pharmacopeial Convention Inc., Rockville, MD (2000).
- ICH, Validation of Analytical Procedures: Text and Methodology Q2 (R1), International Conference on Harmonization, Geneva, November (1996).
References
Escitalopram oxalate. http://www.rxlist.com/cgi/generic/ lexapro.htm (Date accessed 03/01/2012).
W.J. Burke and C.J. Kratochvil, Prim. Care Comp. J. Clin. Psychiatry, 4, 20 (2002).
W.J. Burke, I. Gergel and A. Bose, J. Clin. Psychiatry, 63, 331 (2002).
V.Y. Yevtushenko, A.I. Belous, Y.G. Yevtushenko, S.E. Gusinin, O.J. Buzik and T.V. Agibalova, Clin. Ther., 29, 2319 (2007).
S. Schreiber and C.G. Pick, Eur. Neuropsychopharmacol., 16, 464 (2006).
M.M. Gutierrez, J. Rosenberg and W. Abramowitz, Clin. Ther., 25, 1200 (2003).
C. Sánchez, P.B. Bergqvist, L.T. Brennum, S. Gupta, S. Hogg, A. Larsen and O. Wiborg, Psychopharmacology, 167, 353 (2003).
S. Budavari, The Merck Index, an Encyclopedia of Chemicals, Drugs and Biologicals. Edn. 14th , Merck and Co. Inc., Whitehouse Station, NJ (2001).
S.S. Singh, H. Shah, S. Gupta, M. Jain, K. Sharma, P. Thakkar and R. Shah, J. Chromatogr. B., 811, 209 (2004).
B. Raman, B.A. Sharma, P.D. Ghugare, S. Nandavadekar, D. Singh, P.K. Karmuse and A. Kumar, J. Pharm. Biomed. Anal., 53, 895 (2010).
N. Johannesson and J. Bergquist, J. Pharm. Biomed. Sci., 43, 1045 (2007).
C. Greiner, C. Hiemke, W. Bader and E. Haen, J. Chromatogr. B, 848, 391 (2007).
M. Kosel, C.B. Eap, M. Amey and P. Baumann, J. Chromatogr. B., 719, 234 (1998).
S. Andersen, T.G. Halvorsen, S. Pedersen-Bjergaard, K.E. Rasmussen, L. Tanum and H. Refsum, J. Pharm. Biomed. Anal., 33, 263 (2003).
T. Samanta, S. Dey, H.B. Samal, D.B. Kumar, D.L. Mohanty and K. Bhar, Int. J. Chem. Res., 2, 11 (2011).
A. Suneetha and B.S. Sundar, Int. J. Pharm. Biol. Sci., 2, 140 (2011).
N. Dhavale, S. Gandhi, S. Sabnis and K. Bothara, Chromatographia, 67, 487 (2008).
Y. Shete, N. Pimpodkar, N.S. Mahajan, Y.V. Pore, R.L. Jadhav and B.S. Kuchekar, Int. J. Chem. Sci., 7, 235 (2009).
S. Sharma, H. Rajpurohit, C. Sonwal, A. Bhandari, V.R. Choudhary and T. Jainm J. Young Pharm., 2, 420 (2010).
S.A. Al-Tamimi, F.A. Aly and O.M. Al-Otaibi, Asian J. Chem., 24, 5515 (2012).
R.B. Kakde and D.D. Satone, Indian J. Pharm. Sci., 71, 702 (2009).
B.G. Chaudhari and H.R. Parmar, Int. J. Pharm. Qual. Assur., 2, 9 (2010).
T. Vetrichelvan, K. Arul, M. Sumithra and B. Umadevi, Indian J. Pharm. Sci., 72, 269 (2010).
P. Job, in ed.: B. Oliner, Advanced Physico Chemical Experiments, Edinburgh, UK, p. 54 (1964).
The United States Pharmacopeia, The National Formulary 19, US Pharmacopeial Convention Inc., Rockville, MD (2000).
ICH, Validation of Analytical Procedures: Text and Methodology Q2 (R1), International Conference on Harmonization, Geneva, November (1996).